Trial to activation
Where signups stall before first value, which activation steps are manual, and whether anyone owns the handoff between growth and product.
Segment · B2B SaaS · 20–500 people
You have engineers, a roadmap, and more AI ideas than quarters. What you likely do not have is an independent, priced read of which operating loop is costing you the most — and which AI work is defensible to your board.
What we look at
Where signups stall before first value, which activation steps are manual, and whether anyone owns the handoff between growth and product.
How long implementation actually takes versus what sales promised, and how much of it is one person re-typing the same context.
Whether recurring support themes reach the roadmap as evidence, or arrive as anecdotes in a prioritization meeting.
Which risk signals exist in the data already, who sees them, and how many days pass before anyone acts on one.
How the quarter gets decided, how much of it is the loudest voice, and what evidence a board-level product narrative currently rests on.
Which AI features are worth building into the product versus into your own operations — and which are demos that will not survive contact with pricing.
Fit
It follows the revenue and delivery loops that matter in software: trial-to-activation, onboarding-to-first-value, support-to-product feedback, and renewal risk. The output is a scored map of where those loops leak time or revenue, plus a shortlist of AI opportunities scored against them.
Engineering capacity is rarely the constraint. The constraint is usually deciding which of fifteen plausible AI ideas is worth your team's quarter, and being able to defend that choice to a board. The diagnostic produces that decision, not the code.
Yes. The engagement is designed to leave your team more capable, not dependent. Every artifact is handed over in a form your PMs and analysts can keep running after the engagement ends.
Score yourself in four minutes, read the playbook, or book a free 20-minute call with Aiden Wayne.